oxidopamine has been researched along with ellagic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolatshahi, M; Farbood, Y; Khodadadi, A; Mansouri, SM; Sarkaki, A | 1 |
| Baluchnejadmojarad, T; Rabiee, N; Roghani, M; Zabihnejad, S | 1 |
2 other study(ies) available for oxidopamine and ellagic acid
| Article | Year |
|---|---|
Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease.
Topics: Animals; Antioxidants; Brain; Corpus Striatum; Ellagic Acid; Glutathione Peroxidase; Male; Malondialdehyde; Medial Forebrain Bundle; Models, Animal; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar | 2016 |
Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERĪ²/Nrf2/HO-1 signaling.
Topics: Animals; Antioxidants; Apoptosis; Corpus Striatum; Dopaminergic Neurons; Ellagic Acid; Estrogen Receptor beta; Heme Oxygenase (Decyclizing); Malondialdehyde; Models, Animal; Monoamine Oxidase; Neostriatum; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Pars Compacta; Rats; Reactive Oxygen Species; Signal Transduction; Substantia Nigra | 2017 |